_version_ 1784719182454063104
author Parrondo, Ricardo D.
Rahman, Zaid Abdel
Heckman, Michael G.
Wieczorek, Mikolaj
Jiang, Liuyan
Alkhateeb, Hassan B.
Litzow, Mark R.
Greipp, Patricia
Sher, Taimur
Bergsagel, Leif
Fonseca, Rafael
Roy, Vivek
Dispenzieri, Angela
Kharfan-Dabaja, Mohamed A.
Murthy, Hemant S.
Ailawadhi, Sikander
Foran, James M.
author_facet Parrondo, Ricardo D.
Rahman, Zaid Abdel
Heckman, Michael G.
Wieczorek, Mikolaj
Jiang, Liuyan
Alkhateeb, Hassan B.
Litzow, Mark R.
Greipp, Patricia
Sher, Taimur
Bergsagel, Leif
Fonseca, Rafael
Roy, Vivek
Dispenzieri, Angela
Kharfan-Dabaja, Mohamed A.
Murthy, Hemant S.
Ailawadhi, Sikander
Foran, James M.
author_sort Parrondo, Ricardo D.
collection PubMed
description
format Online
Article
Text
id pubmed-9160012
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-91600122022-06-03 Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma Parrondo, Ricardo D. Rahman, Zaid Abdel Heckman, Michael G. Wieczorek, Mikolaj Jiang, Liuyan Alkhateeb, Hassan B. Litzow, Mark R. Greipp, Patricia Sher, Taimur Bergsagel, Leif Fonseca, Rafael Roy, Vivek Dispenzieri, Angela Kharfan-Dabaja, Mohamed A. Murthy, Hemant S. Ailawadhi, Sikander Foran, James M. Blood Cancer J Correspondence Nature Publishing Group UK 2022-06-01 /pmc/articles/PMC9160012/ /pubmed/35650175 http://dx.doi.org/10.1038/s41408-022-00680-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Parrondo, Ricardo D.
Rahman, Zaid Abdel
Heckman, Michael G.
Wieczorek, Mikolaj
Jiang, Liuyan
Alkhateeb, Hassan B.
Litzow, Mark R.
Greipp, Patricia
Sher, Taimur
Bergsagel, Leif
Fonseca, Rafael
Roy, Vivek
Dispenzieri, Angela
Kharfan-Dabaja, Mohamed A.
Murthy, Hemant S.
Ailawadhi, Sikander
Foran, James M.
Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma
title Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma
title_full Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma
title_fullStr Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma
title_full_unstemmed Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma
title_short Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma
title_sort unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9160012/
https://www.ncbi.nlm.nih.gov/pubmed/35650175
http://dx.doi.org/10.1038/s41408-022-00680-y
work_keys_str_mv AT parrondoricardod uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma
AT rahmanzaidabdel uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma
AT heckmanmichaelg uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma
AT wieczorekmikolaj uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma
AT jiangliuyan uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma
AT alkhateebhassanb uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma
AT litzowmarkr uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma
AT greipppatricia uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma
AT shertaimur uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma
AT bergsagelleif uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma
AT fonsecarafael uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma
AT royvivek uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma
AT dispenzieriangela uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma
AT kharfandabajamohameda uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma
AT murthyhemants uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma
AT ailawadhisikander uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma
AT foranjamesm uniquecharacteristicsandoutcomesoftherapyrelatedacutelymphoblasticleukemiafollowingtreatmentformultiplemyeloma